Роль лобно-подкорковых связей в развитии обсессивно-компульсивных расстройств
https://doi.org/10.14412/2074-2711-2016-2-107-112
Аннотация
Представлен краткий обзор исследований, посвященных роли нарушений лобно-подкорковых связей в развитии обсессивно-компульсивного расстройства (ОКР). Приведены данные о частоте неврозоподобных симптомов спектра ОКР при неврологических заболеваниях.
Развитие ОКР связано с нарушением баланса между активностью прямого (активирующего) и непрямого (тормозящего) путей корково-стрио-таламо-корковой петли обратной связи. Эти данные подтверждаются результатами нейровизуализационных и нейропсихологических исследований пациентов с ОКР. Высока частота симптомов ОКР при органических поражениях головного мозга. ОКР могут быть проявлением неврологических заболеваний, поэтому их своевременное выявление – важный аспект работы невролога. Лечение пациентов с неврозоподобными расстройствами спектра ОКР в рамках неврологических заболеваний требует мультдисциплинарного подхода с участием невролога, психиатра/психотерапевта, психолога. Необходимо сочетание патогенетического лечения основного заболевания и его неврозоподобных проявлений.
Об авторе
М. А. КутлубаевРоссия
Отделение неврологии
кафедра неврологии с курсами нейрохирургии и медицинской генетики
450005, ул. Достоевского,132, Уфа, Башкортостан
450000, Республика Башкортостан, Уфа, ул. Ленина, 3
Список литературы
1. Grant JE. Obsessive-compulsive disorder. N Engl J Med. 2014 Aug 14;371(7):646-53. doi: 10.1056/NEJMcp1402176.
2. Pauls DL, Abramovitch A, Rauch SL, Geller DA. Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci. 2014 Jun;15(6):410- 24. doi: 10.1038/nrn3746.
3. Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am. 2000 Sep;23(3):563-86.
4. Milad MR, Rauch SL. Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci. 2012 Jan;16(1): 43-51. doi: 10.1016/j.tics.2011.11.003. Epub 2011 Dec 2.
5. Luxenberg JS, Swedo SE, Flament MF, et al. Neuroanatomical abnormalities in obsessive compulsive disorder determined with quantitative x-ray computed tomography. Am J Psychiatry. 1988 Sep;145(9):1089-93.
6. Robinson D, Wu H, Munne RA, Ashtari M, et al. Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry. 1995 May;52(5):393-8.
7. Burguiеre E, Monteiro P, Mallet L, et al. Striatal circuits, habits, and implications for obsessive-compulsive disorder. Curr Opin Neurobiol. 2015 Feb;30:59-65. doi: 10.1016/ j.conb.2014.08.008. Epub 2014 Sep 19.
8. Baxter LR Jr. Neuroimaging studies of obsessive-compulsive disorder. Psychiatr Clin North Am. 1992 Dec;15(4):871-84.
9. Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl. 1998;(35):26-37.
10. Menzies L, Chamberlain SR, Laird AR, et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev. 2008;32(3):525-49. Epub 2007 Oct 17.
11. Fitzgerald KD, Welsh RC, Stern ER et al. Developmental alterations of frontal-striatalthalamic connectivity in obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2011 Sep;50(9):938-948.e3. doi: 10.1016/j.jaac. 2011.06.011. Epub 2011 Jul 31.
12. Koch K, Wagner G, Schachtzabel C, et al. White matter structure and symptom dimensions in obsessive-compulsive disorder. J Psychiatr Res. 2012 Feb;46(2):264-70. doi: 10.1016/j.jpsychires.2011.10.016. Epub 2011 Nov 17.
13. Harrison BJ, Pujol J, Cardoner N, et al. Brain corticostriatal system and the major clinical symptom dimensions of obsessive-compulsive disorder. Biol Psychiatry. 2013 Feb 15; 73(4):321-8. doi: 10.1016/j.biopsych.2012.10. 006. Epub 2012 Nov 28.
14. Brennan BP, Rauch SL, Jensen JE, Pope HG Jr. A critical review of magnetic resonance spectroscopy studies of obsessivecompulsive disorder. Biol Psychiatry. 2013 Jan 1;73(1):24-31. doi: 10.1016/j.biopsych. 2012.06.023. Epub 2012 Jul 24.
15. Rosenberg DR, MacMaster FP, Keshavan MS, et al. Decrease in caudate glutamatergic concentrations in pediatric obsessivecompulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry. 2000 Sep;39(9):1096-103.
16. Burguiere E, Monteiro P, Feng G, Graybiel AM. Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors. Science. 2013 Jun 7; 340(6137):1243-6. doi: 10.1126/science.1232380.
17. Pearlman DM, Vora HS, Marquis BG, et al. Anti-basal ganglia antibodies in primary obsessive-compulsive disorder: systematic review and meta-analysis. Br J Psychiatry. 2014 Jul;205(1): 8-16. doi: 10.1192/bjp.bp.113.137018.
18. Slattery MJ, Dubbert BK, Allen AJ, et al. Prevalence of obsessive-compulsive disorder in patients with systemic lupus erythematosus. J Clin Psychiatry. 2004 Mar;65(3):301-6.
19. Dougherty DD, Baer L, Cosgrove GR, et al. Prospective long-term follow up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder. Am J Psychiatry. 2002 Feb;159(2):269-75.
20. Kaplan & Sadock's Comprehensive Textbook of Psychiatry. 9th Ed.. Lippincott Williams & Wilkins; 2009. 4884 p.
21. Baxter LR Jr, Schwartz JM, Bergman KS, et al. Caudate glucose metabolic-rate changes with both drug and behavior-therapy for obsessive-compulsive disorder. Arch Gen Psychiatry. 1992 Sep;49(9):681-9.
22. Saxena S, Brody AL, Maidment KM, et al. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology. 1999 Dec;21(6):683-93.
23. Schwartz JM, Stoessel PW, Baxter LR Jr, et al. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1996 Feb;53(2):109-13.
24. Freyer T, Klö ppel S, Tü scher O, et al. Frontostriatal activation in patients with obsessive-compulsive disorder before and after cognitive behavioral therapy. Psychol Med. 2011 Jan;41(1):207-16. doi: 10.1017/ S0033291710000309. Epub 2010 Mar 18.
25. Saxena S, Brody AL, Ho ML, et al. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder versus major depression. Am J Psychiatry. 2003 Mar;160(3):522-32.
26. Saxena S, Gorbis E, O'Neill J, et al. Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Mol Psychiatry. 2009 Feb;14(2):197-205. doi: 10.1038/sj.mp.4002134. Epub 2008 Jan 8.
27. de Koning PP, Figee M, van den Munckhof P, et al. Current status of deep brain stimulation for obsessive-compulsive disorder: a clinical review of different targets. Curr Psychiatry Rep. 2011 Aug;13(4):274-82. doi: 10.1007/s11920- 011-0200-8.
28. Norberg MM, Krystal JH, Tolin DF. A meta-analysis of D cycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry. 2008 Jun 15;63(12):1118-26. doi: 10.1016/j.biopsych.2008.01.012. Epub 2008 Mar 7.
29. Abramovitch, A, Dar R, Schweiger A, Hermesh H. Neuropsychological impairments and their association with obsessive-compulsive symptom severity in obsessive-compulsive disorder. Arch Clin Neuropsychol. 2011 Jun;26(4): 364-76. doi: 10.1093/arclin/acr022. Epub 2011 Apr 14.
30. Penadеs R, Catalаn R, Rubia K, et al. Impaired response inhibition in obsessive compulsive disorder. Eur Psychiatry. 2007 Sep;22(6):404-10.
31. Boone KB. Philpott L. Neuropsychological characteristics of nondepressed adults with obsessive-compulsive disorder. Cogn. Behav. Neurol. 1991;(4): 96-109.
32. Rao, NP, Reddy YC, Kumar KJ, et al. Are neuropsychological deficits trait markers in OCD? Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1574-9. doi: 10.1016/j.pnpbp.2008.05.026. Epub 2008 Jun 8.
33. Figee M, Vink M, de Geus F, et al. Dysfunctional reward circuitry in obsessivecompulsive disorder. Biol Psychiatry. 2011 May 1;69(9):867-74. doi: 10.1016/j.biopsych.2010. 12.003. Epub 2011 Jan 26.
34. Jung WH, Kang DH, Han JY, et al. Aberrant ventral striatal responses during incentive processing in unmedicated patients with obsessive-compulsive disorder. Acta Psychiatr Scand. 2011 May;123(5):376-86. doi: 10.1111/j.1600-0447.2010.01659.x. Epub 2010 Dec 22.
35. Bienvenu OJ, Samuels JF, Wuyek LA, et al. Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol Med. 2012 Jan;42(1):1-13. doi: 10.1017/ S0033291711000742. Epub 2011 May 13.
36. Chamberlain SR, Fineberg NA, Menzies LA, et al. Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007 Feb;164(2):335-8.
37. Rajender G, Bhatia MS, Kanwal K, et al. Study of neurocognitive endophenotypes in drug-naive obsessive-compulsive disorder patients, their first-degree relatives and healthy controls. Acta Psychiatr Scand. 2011 Aug;124(2):152-61. doi: 10.1111/j.1600- 0447.2011.01733.x. Epub 2011 Jun 16.
38. Jaafari N, Fernаndez de la Cruz L, Grau M, et al. Neurological soft signs in obsessive-compulsive disorder: two empirical studies and meta-analysis. Psychol Med. 2013 May;43(5): 1069-79. doi: 10.1017/S0033291712002012. Epub 2012 Aug 30.
39. Isaacs KL, Philbeck JW, Barr WB, et al. Obsessive-compulsive symptoms in patients with temporal lobe epilepsy. Epilepsy Behav. 2004 Aug;5(4):569-74.
40. Kaplan PW. Obsessive-compulsive disorder in chronic epilepsy. Epilepsy Behav. 2011 Nov;22(3):428-32. doi: 10.1016/j.yebeh. 2011.07.029. Epub 2011 Sep 1.
41. Foroughipour M, Behdani F, Hebrani P, et al. Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: A crosssectional study. J Res Med Sci. 2012 Mar;17(3):248-53.
42. Tinelli E, Francia A, Quartuccio EM, et al. Structural Brain MR Imaging Changes Associated with Obsessive-Compulsive Disorder in Patients with Multiple Sclerosis. AJNR Am J Neuroradiol. 2013 Feb;34(2):305-9. doi: 10.3174/ajnr.A3210. Epub 2012 Jul 19.
43. Harbishettar V, Pal PK, Janardhan Reddy YC, Thennarasu K. Is there a relationship between Parkinson's disease and obsessive-compulsive disorder? Parkinsonism Relat Disord. 2005 Mar;11(2):85-8.
44. Alegret M, Junque C, Valldeoriola F, et al. Obsessive-compulsive symptoms in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2001 Mar;70(3):394-6.
45. Weintraub D. Impulse control disorders in Parkinson's disease: prevalence and possible risk factors. Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S110-3. doi: 10.1016/S1353- 8020(09)70794-1.
46. Никитина АВ, Федорова НВ. Импульсивно-компульсивный синдром при болезни Паркинсона. Журнал неврологии и психиатрии им. С.С. Корсакова. 2013; (7 Вып. 2):32-8. [Nikitina AV, Fedorova NV. Impulsive-compulsive syndrome in Parkinson's disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;(7 Pt. 2):32-8. (In Russ.)].
47. Singer HS. Neurobiology of Tourette syndrome. Neurol Clin. 1997 May;15(2):357-79.
48. Wu MS, Horng B, Storch EA. A case report on obsessive-compulsive disorder and low-grade astrocytomas. Ann Clin Psychiatry. 2013 Nov; 25(4):309-10.
49. Kumar V, Chakrabarti S, Modi M, Sahoo M. Late-onset obsessive compulsive disorder associated with possible gliomatosis cerebri. World J Biol Psychiatry. 2009;10(4 Pt 2): 636-9. doi: 10.1080/15622970903036846.
50. Hegde A, Ghosh A, Grover S, et al. Arachnoid cyst masquerades as late onset obsessive-compulsive disorder. Gen Hosp Psychiatry. 2014 Jan-Feb;36(1):125.e7-9. doi: 10.1016/j. genhosppsych.2013.09.002. Epub 2013 Oct 29.
51. Liu J, Zhang X, Liu J. Obsessions appear after the removal a brain tumor in the right frontal lobe. Gen Hosp Psychiatry. 2014 Jul-Aug;36(4):450.e3-4. doi: 10.1016/j.genhosppsych.2014.02.007. Epub 2014 Mar 5.
52. Rogers MP, Mendoza AY. Development of obsessive-compulsive disorder after brain tumor surgery and radiation. Psychosomatics. 1994 Jul-Aug;35(4):402-6.
53. Pewter SM, Williams WH, Haslam C, et al. Neuropsychological and psychiatric profiles in acute encephalitis in adults. Neuropsychol Rehabil. 2007 Aug-Oct;17(4-5):478-505.
54. Grados MA, Vasa RA, Riddle MA, et al. New onset obsessive-compulsive symptoms in children and adolescents with severe traumatic brain injury. Depress Anxiety. 2008;25(5):398-407.
Рецензия
Для цитирования:
Кутлубаев МА. Роль лобно-подкорковых связей в развитии обсессивно-компульсивных расстройств. Неврология, нейропсихиатрия, психосоматика. 2016;8(2):107-112. https://doi.org/10.14412/2074-2711-2016-2-107-112
For citation:
Kutlubaev MA. The role of frontal-subcortical circuits in the development of obsessive-compulsive disorders. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2016;8(2):107-112. (In Russ.) https://doi.org/10.14412/2074-2711-2016-2-107-112